A "new contender" (and a client) enters the #TcellEngager and #Bispecific #ADC arena with a novel, conditionally activated TCE strategy called #BiTAC. Interested to hear people’s thoughts on this one...

#AACR2026 #CancerResearch #Immunotherapy